Association of convalescent plasma therapy with survival in patients with blood cancers, COVID-19
3 institutional releases
Published in JAMA Oncology · View the paper (DOI)
Researchers investigated the association between convalescent plasma treatment and mortality in hospitalized adults with hematologic cancers and COVID-19. The study found that convalescent plasma therapy was associated with improved survival rates among these patient groups.
Coverage from 3 institutions
- Association of convalescent plasma therapy with survival in patients with blood cancers, COVID-19 JAMA Network · Jun 17, 2021 · first to report
- Convalescent plasma improves survival in COVID-19 patients with blood cancers University of Texas Health Science Center at San Antonio · Jun 17, 2021
- Blood cancer patients with COVID-19 fare better with convalescent plasma Washington University in St. Louis · Jun 17, 2021